改訂2版　新生児の心エコー入門

出版社： メディカ出版
著者：
発行日： 2024-07-20
分野： 臨床医学：内科  >  周産期(新生児)
ISBN： 9784840485067
電子書籍版： 2024-07-20 （電子書籍版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：約3営業日

14,300 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

14,300 円(税込)

購入する

商品紹介

適切な手技で的確な心エコー所見を得て、病態に応じた循環管理を展開することが、新生児を診る医師には求められる。循環管理の基本から、心形態の観察、心機能評価、先天性心疾患の管理まで、スマートフォンですぐアクセスできる超音波動画で解説。心エコーと新生児循環管理の最前線もこの一冊に。心エコー検査の習熟を目指す新生児科医・小児循環器科医必携の書。

目次

  • 【Chapter I　新生児心エコーことはじめ】
    ■1　新生児の循環生理
    ■2　心エコー検査前に確認しておくべき循環症状
    ■3　エコー検査実施前の環境整備とエコーの基本

    【Chapter II　形態の観察】
    ■1　四腔断面
    ■2　五腔断面
    ■3　二腔断面
    ■4　短軸断面
    ■5　長軸断面
    ■6　大動脈弓断面
    ■7　剣状突起下断面
    ■8　右胸壁アプローチ

    【Chapter III　機能の評価】
    ■1　心機能評価
    ■2　内大脳静脈血流波形の揺らぎ
    ■3　臓器血流の評価
    ■4　2次元スペックルトラッキング法
    ■5　3次元エコー

    【Chapter IV　生後早期の適応障害と先天性心疾患】
    ■1　未熟児動脈管開存症（未熟児PDA）
    ■2　生後早期の早産児循環不全（Stress-Velocity関係の活用法）
    ■3　新生児遷延性肺高血圧症（PPHN）
    ■4　新生児遷延性肺高血圧症と鑑別すべき心疾患
    ■5　重症先天性心疾患の胎児診断
    ■6　総肺静脈還流異常症（TAPVC）
    ■7　完全大血管転位症（TGA）
    ■8　動脈管依存性先天性心疾患
    ■9　心室中隔に欠損孔がある心疾患
    ■10　双胎間輸血症候群（TTTS）
    ■11　新生児慢性肺疾患に合併した肺高血圧症（CLD-PH）

    【Chapter V　循環作動薬の使い方】

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

Chapter I 新生児心エコーことはじめ

P.2 掲載の参考文献
1) Rudolph AM. "Perinatal and postnatal changes in the circulation". Congenital Diseases of the Heart. New York, Futura Publishing, 2001, 20-9.
 
2) 豊島勝昭ほか. 極低出生体重児における左室壁応力・心筋短縮速度の経時的変化と肺出血・脳室内出血・脳室周囲白質軟化症の関連性について. 日本未熟児新生児学会雑誌. 14, 2002, 45-52.
 
3) 豊島勝昭ほか. Stress-Velocity 関係を指標として循環管理した在胎23, 24週の超早産児の検討. 日本周産期・新生児医学会雑誌. 41, 2005, 535-41.
 
4) Levick JR. "心血管系の概観". 心臓・循環の生理学. 岡田隆夫監訳. 東京, メディカル・サイエンス・インターナショナル, 2011, 1-14.
 
5) Nelson, NM. "Respiration and circulation before birth". The Physiology of the Newborn Infant. 4th ed. Springfield, Charles C. Thomas, 1976, 771p.
 
6) Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 341(8), 1999, 577-85.
 
7) 仁志田博司, 八代公夫. 綜説 新生児瞬時心拍数のモニタリング(Neonatal Instantaneous Heart Rate Monitoring):第1編 瞬時心拍数と心拍数調節機構. 周産期医学. 9(9), 1979, 1281-91.
 
8) 豊島勝昭. "心不全における内分泌調整". 新版 新生児内分泌ハンドブック. 大阪, メディカ出版, 2020, 272-86.
 
9) Cameron VA, Ellmers LJ. Minireview:natriuretic peptides during development of the fetal heart and circulation. Endocrinology. 144(6), 2003, 2191-4.
 
10) 豊島勝昭ほか. 胎児心機能障害におけるナトリウム利尿ペプチドホルモンの臨床的意義. 日本小児循環器学会雑誌. 21(2), 2005, 123-9.
 
11) Toyoshima K, et al. In vivo dilatation of the postnatal ductus arteriosus by atrial natriuretic peptide in the rat. Neonatology. 92(2), 2007, 139-44.
 
12) 木村朋生ほか. "代償性のレニン・アンジオテンシン・アルドステロン系の亢進が心不全を悪化させる". 臨床心不全のいちばん大事なところ. 大阪, メディカ出版, 2014, 57.
 
13) 豊島勝昭. "循環器系の基礎と臨床". 新生児学入門. 第5版. 東京, 医学書院, 2018, 196-227.
 
P.16 掲載の参考文献
1) 豊島勝昭. "心臓:機能評価法". 目でみる最新の超音波診断. 小児科診療71巻増刊. 東京, 東京医学社, 2008, 197-209.
 
2) Kemper AR., et al. Strategies for implementing screening for critical congenital heart disease. Pediatrics. 128(41), 2011, e1259-67.
 
3) 中野玲二, 豊島勝昭ほか. パルスオキシメータによる重症先天性心疾患の出生後スクリーニングに関するアンケート調査結果. 日本周産期・新生児医学会雑誌. 58(1), 2022, 92-7.
 
4) 中野玲二, 豊島勝昭ほか. パルスオキシメータによる重症先天性心疾患の出生後スクリーニングの標準化プロトコール案. 日本新生児成育医学会雑誌. 31(3), 2019, 715.
 
5) 豊島勝昭. 循環. 周産期医学. 40(6), 2016, 845-50.
 
6) 豊島勝昭. "チアノーゼ". 症候からみた小児の診断学. 小児科診療70巻増刊. 東京, 東京医学社, 2007, 168-71.
 
7) 豊島勝昭. "心雑音". 周産期の症候・診断・治療. 周産期医学37巻増刊. 東京, 東京医学社, 2007, 401-4.
 
P.32 掲載の参考文献
1) 豊島勝昭. "心臓:機能評価法". 目でみる最新の超音波診断. 小児科診療71巻増刊. 東京, 診断と治療社, 2008, 197-209.
 
2) 豊島勝昭. "心臓超音波検査法". 小児の治療指針. 小児科診療73巻増刊. 東京, 診断と治療社, 2010, 1525-32.
 

Chapter II 形態の観察

P.46 掲載の参考文献
1) 豊島勝昭ほか. 先天性心疾患の出生前診断における弁輪径測定の有用性. 日本新生児学会雑誌. 37(1), 2001, 29-35.
 
P.59 掲載の参考文献
1) Gonzalez LD, et al. Tuberous Sclerosis Associated With Aortic Stenosis and Endocarditis:A Case Report. Cureus. 15(5), 2023, e38480.
 
2) Adyanthaya AV, et al. Membranous subvalvular aortic stenosis in tuberous sclerosis. Chest. 61(4), 1972, 407-8.
 
3) Sandoval-Tress C, et al. Valvular and subvalvular aortic stenosis. Unusual expression of tuberous sclerosis. An Pediatr(Barc). 71(5), 2009, 467-8.
 
4) Mair DD, et al. Cardiac rhabdomyoma simulating mitral atresia. Chest. 71(1), 1977 102-5.
 
5) Pernot C, et al. Radiological patterns of obstructive cardiomyopathy of the left ventricle in childhood. Am Heart J. 86(4), 1973, 462-6.
 
6) 池田早希ほか. 大動脈弁直下横紋筋腫に対して外科的切除を施行した結節性硬化症の1例. 日本未熟児新生児学会雑誌. 25(3), 2013, 601.
 
P.68 掲載の参考文献
1) 豊島勝昭ほか. 先天性心疾患の出生前診断における弁輪径測定の有用性. 日本新生児学会雑誌. 37(1), 2001, 29-35.
 
P.100 掲載の参考文献
1) Sato Y, et al. The diameter of the inferior vena cava provides a noninvasive way of calculating central venouspressure in neonates. Acta Paediatr. 102(6), 2013, e241-6.
 
2) Kishigami M, et al. Ultrasound-guided umbilical venous catheter insertion with alignment of the umbilical veinand ductus venosus. J Ultrasound Med. 39(2), 2020, 379-83.
 

Chapter III 機能の評価

P.114 掲載の参考文献
1) Rudolph AM. "Perinatal and postnatal changes in the circulation". Congenital Diseases of the Heart:Clinical-Physiological Considerations. 3rd ed. Oxford, John Wiley & Sons, 2009, 25-36.
 
2) 中西俊雄. "心臓大血管の発生と血行動態". 臨床発達心臓病学. 第3版. 高尾篤良編. 東京, 中外医学社, 2001, 42-52.
 
3) 豊島勝昭ほか. 極低出生体重児における左室壁応力・心筋短縮速度の経時的変化と肺出血・脳室内出血・脳室周囲白質軟化症の関連性について. 日本未熟児新生児学会雑誌. 14(2), 2002, 45-52.
 
4) 豊島勝昭. Stress-Velocity関係を指標として循環管理した在胎23, 24週の超早産児の検討. 日本周産期・新生児医学会雑誌. 41, 2005, 535-42.
Medical*Online
5) 豊島勝昭. 脳保護を目指した在胎25週未満の超低出生体重児の至適血圧の検討. 日本周産期・新生児医学会雑誌. 45(4), 2009, 1201-4.
 
6) Toyoshima K. Tailor-made circulatory management based on the stress-velocity relationship in preterm infants. J Formos Med Assoc. 112(9), 2013, 510-7.
 
7) Romeo TE, Friedman WF. Limited left ventricular response to volume overload in the neonate period:a comparative study with the adult animal. Pediatr Res. 13(8), 1979, 910-5.
 
8) Sato Y, et al. The diameter of the inferior vena cava provides a noninvasive way of calculating central venous pressure in neonates. Acta Paediatr. 102(6), 2013, e241-6.
 
9) Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med. 322(2), 1990, 100-10.
 
10) Lang RM, et al. Recommendations for chamber quantification:a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 18(12), 2005, 1440-63.
 
11) Pritchett AM, et al. Diastolic dysfunction and left atrial volume:a population-based study. J Am Coll Cardiol. 45(1), 2005, 87-92.
 
12) Toyoshima K, et al. Left atrial volume is superior to the ratio of the left atrium to aorta diameter for assessment of the severity of patent ductus arteriosus in extremely low birth weight infants. Circ J. 78(7), 2014, 1701-9.
 
13) 甘利昭一郎ほか. 新生児科医による心エコー静止画上の計測の検者間信頼性. 日本新生児成育医学会雑誌. 29(2), 2017, 99-108.
 
14) Murata M, et al. A real-time three-dimensional echocardiographic quantitative analysis of left atrial function in left ventricular diastolic dysfunction. Am J Cardiol. 102(108), 2008, 1097-102.
 
15) 豊島勝昭ほか. 新生児慢性肺疾患と肺高血圧症:新生児期の肺高血圧と心肺連関を考える. 日本小児呼吸器学会雑誌. 29(2), 2018, 171-7.
 
16) 中澤誠. 心機能の発達. 日本新生児学会雑誌. 25, 1989, 721-6.
 
17) Grenville FF. Pulmonary hemorrhage. Neonatal Respiratory Disorders. Greenoough A. eds. London, Arnold, 2003, 365-72.
 
18) Moody DM, et al. Alkaline phosphatase histochemical staining in the study of germinal matrix hemorrhage and brain vascular morphology in a very-low-birth-weight neonate. Pediatr Res. 35(4 Pt), 1994, 424-30.
 
19) Ghazi-Birry HS, et al. Human germinal matrix:venous origin of hemorrhage and vascular characteristics. AJNR Am J Neuroradiol. 18(2), 1997, 219-29.
 
20) Colan SD, et al. Left ventricular end-systolic wall stress-velocity of fiber shortening relation:A load-independent index of myocardial contractility. J Am Coll Cardol. 4(4), 1984, 715-24.
 
21) Skinner J. Physics of ultrasound and imaging the structurally normal heart. Echocardiography for the Neonatologists. London, Churchill Livingstone, 2000, 3-87.
 
22) Kluckow M, Evans N. Superior vena cava flow in newborn infants:a novel marker of systemic blood flow. Arch Dis Child Fetal Neonatal Ed. 82(3), 2000, F182-7.
 
23) Kluckow M, Evans N. Low systemic blood flow and hyperkalemia in preterm infants. J Pediatr. 139(2), 2001, 227-32.
 
24) Osborn DA, et al. Hemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatrics. 112(1 Pt 1), 2003, 33-9.
 
P.138 掲載の参考文献
1) 豊島勝昭ほか. 脳保護を目指した在胎25週未満の超低出生体重児の至適血圧の検討. 日本周産期・新生児医学会雑誌. 45(4), 2009, 1201-4.
 
2) 豊島勝昭ほか. 超低出生体重児の急性期循環管理における塩酸モルヒネ静注療法の有効性と安全性について. 周産期学シンポジウム. 29, 2011, 95-102.
 
3) Ikeda T, et al. Changes in the perfusion waveform of the internal cerebral vein and intraventricular hemorrhage in the acute management of extremely low-birth-weight infants. Eur J Pediatr. 174(3), 2015, 331-8.
 
4) Ikeda T, et al. Hemodynamics of infants with strong fluctuations of internal cerebral vein. Pediatr Int. 2019 61(5), 2019, 475-81.
 
5) Ikeda, T. et al. Fluctuations in internal cerebral vein and central side veins of preterm infants. Pediatr Int 63(11), 2021, 1319-26.
 
6) Tanaka, K. et al. Reversal of blood flow in deep cerebral vein in preterm intraventricular hemorrhage:two case reports. BMC Pediatr. 20(1), 2020, 517.
 
7) Tanaka, K. et al. Changes in Internal Cerebral Vein Pulsation and Intraventricular Hemorrhage in Extremely Preterm Infants. Am J Perinatol. 41(S 01), 2024, e37-e45.
 
8) Tanaka, K. et al. Change over time in internal cerebral vein pulsation in premature infants at risk of intraventricular hemorrhag. Early Hum Dev 179, 2023, 105747.
 
P.146 掲載の参考文献
1) 増谷聡. 2D Speckle tracking法を始めよう. 日本小児循環器学会雑誌. 32(2), 2016, 78-86.
 
2) Voigt JU, et al. Definitions for a common standard for 2D speckle tracking echocardiography:consensus document of the EACVI/ASE/Industry Task Force to standardize defor- mation imaging. J Am Soc Echocardiogr. 28(2), 2015, 183-93.
 
3) Patel N, et al. Early postnatal ventricular dysfunction is associated with disease severity in patients with congenital diaphragmatic hernia. J Pediatr. 203, 2018, 400-7.
PubMed
4) de Waal K, et al. Speckle tracking echocardiography in very preterm infants:feasibility and reference values. Early Hum Dev. 90(6), 2014, 275-9.
 
5) de Waal K, et al. Cardiac Function After the Immediate Transitional Period in Very PretermInfants Using Speckle Tracking Analysis. Pediatr Cardiol. 37(2), 2016, 295-303.
 
6) Castaldi B, et al. Early modifications of cardiac function in preterm neonates using speckletracking echocardiography. Echocardiography. 35(6), 2018, 849-54.
 
7) Levy PT, et al. Feasibility and reproducibility of systolic right ventricular strain measurement by speckle-tracking echocardiography in premature infants. J Am Soc Echocardiogr. 26(10), 2013, 1201-13.
 
8) Levy PT, et al. Maturational patterns of systolic ventricular deformation mechanics by two-dimensional speckletracking echocardiography in preterm infants over the first year of age. J Am Soc Echocardiogr. 30(7), 2017, 685-98.
 
9) de Waal K, et al. Speckle tracking echocardiography in very preterm infants:feasibility and reference values. Early Hum Dev. 90(6), 2014, 275-9.
 
10) de Waal K, et al. Cardiac Function After the Immediate Transitional Period in Very PretermInfants Using Speckle Tracking Analysis. Pediatr Cardiol. 37(2), 2016, 295-303.
 
11) Castaldi B, et al. Early modifications of cardiac function in preterm neonates using speckletracking echocardiography. Echocardiography. 35(6), 2018, 849-54.
 
12) Levy PT, et al. Feasibility and reproducibility of systolic right ventricular strain measurement by speckletracking echocardiography in premature infants. J Am Soc Echocardiogr. 26(10), 2013, 1201-13.
 
13) Levy PT, et al. Maturational Patterns of Systolic Ventricular Deformation Mechanics by Two-Dimensional Speckle-Tracking Echocardiography in Preterm Infants over the First Year of Age. J Am Soc Echocardiogr. 30(7), 2017, 685-98.
 
14) Voigt JU, et al. Definitions for a common standard for 2D speckle tracking echocardiography:consensus document of the EACVI/ASE/Industry Task Force to standardize defor- mation imaging. J Am Soc Echocardiogr. 28, 2015, 183-93.
 
15) Sengelov M, et al. Global longitudinal strain is a superior predictor of all-cause mortality in heart failure with reduced ejection fraction. JACC Cardiovasc Imaging. 8(12), 2015, 1351-9.
 
16) Farsalinos KE, et al. Head-to-Head comparison of global longitudinal strain measurements among nine different vendors:The EACVI/ASE Inter-Vendor Comparison Study. J Am Soc Echocardiogr. 28(10), 2015, 1171-81.
 
17) Lang RM, et al. Recommendations for cardiac chamber quantification by echocardiography in adults:an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 28(1), 2015, 1-39.
 
18) Hamada-Harimura Y, et al. Incremental prognostic value of right ventricular strain in patients with acute decompensated heart failure. Circ Cardiovasc Imaging. 11(10), 2018, e007249.
 
19) Fukuda Y. Utility of right ventricular free wall speckle-tracking strain for evaluation of right ventricular performance in patients with pulmonary hypertension. J Am Soc Echocardiogr. 24(10), 2011, 1101-8.
 
20) Rimbas RC. Sources of variation in assessing left atrial functions by 2D speckle-tracking echocardiography. Heart Vessels. 31(3), 2016, 370-81.
 
21) Pathan F, et al. Normal ranges of left atrial strain by speckle-tracking echocardiography:A systematic review and metaanalysis. J Am Soc Echocardiogr. 30(1), 2017, 59-70.
 
21) 豊島勝昭ほか. Small for gestational age(SGA)の3次元エコー検査による左右心室機能評価. 日本新生児成育医学会雑誌. 35(3), 2023, 605.
 
22) 豊島勝昭ほか. 早産児動脈管開存症に対する外科治療前後のスペクトルトラッキング法による両心室ストレイン解析. 日本新生児成育医学会雑誌. 35(3), 2023, 606.
 
P.153 掲載の参考文献
1) Sheikh K, et al. Real-time, three-dimensional echocardiography:feasibility and initial use. Echocardiography. 8(1), 1991, 119-25.
 
2) Kisslo J, et al. Real-time volumetric echocardiography:the technology and the possibilities. Echocardiography. 17(8), 2000, 773-9.
 
3) Sugeng L, et al. Biplane stress echocardiography using a prototype matrix-array transducer. J Am Soc Echocardiogr. 16(9), 2003, 937-41.
 
4) 神谷雄作ほか. 早産児の3次元心臓超音波検査:検者間誤差改善への取り組み. 日本新生児成育医学会雑誌. 32(1), 2020, 149-60.
 
5) Sugeng L, et al. Quantitative assessment of left ventricular size and function:side-by-side comparison of real-time three-dimensional echocardiography and computed tomography with magnetic resonance reference. Circulation. 114(7), 2006, 654-61.
 
6) Jenkins C, et al. Left ventricular volume measurement with echocardiography:a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. Eur Heart J. 30(1), 2009, 98-106.
 
7) Buccheri S, et al. Reference values for real time three-dimensional echocardiography-derived left ventricular volumes and ejection fraction:review and meta-analysis of currently available studies. Echocardiography. 32(12), 2015, 1841-50.
 
8) 山本裕ほか. 3Dエコーを用いた新生児左室容積:VLBWにおけるStress-Velocity関係を含めた検討. 日本周産期・新生児医学会雑誌. 44(2), 2008, 408.
 
9) 山本裕ほか. 新生児における3D エコーによる右室機能解析:容量曲線に着目して. 日本新生児成育医学会雑誌. 31(3), 2019, 631.
 
10) 豊島勝昭ほか. 極低出生体重児における3次元心エコー法による容積・駆出率計測の臨床的意義. 日本未熟児新生児学会雑誌. 25(3), 2013, 45.
 
11) 豊島勝昭ほか. Small for gestational age(SGA)の3次元エコー検査による左右心室機能評価. 日本新生児成育医学会雑誌. 35(3), 2023, 605.
 
12) Murata M, et al. A real-time three-dimensional echocardiographic quantitative analysis of left atrial function in left ventricular diastolic dysfunction. Am J Cardiol. 102(8), 2008, 1097-102.
 
13) Iwataki M, et al. Measurement of left atrial volume from transthoracic three-dimensional echocardiographic datasets using the biplane Simpson's technique. J Am Soc Echocardiogr. 25(12), 2012, 1319-26.
 
14) Takeuchi M, et al. Left ventricular and left atrial volume ratio assessed by three-dimensional echocardiography:Novel indices for evaluating age-related change in leftheart chamber size. Physiol Rep. 7(23), 2019, e14300.
 
15) Ghelani SJ, et al. Left atrial volumes and strain in healthy children measured by three-dimensional echocardiography:normal values and maturational changes. J Am Soc Echocardiogr. 31(2), 2018, 187-193. e1.
 
16) 豊島勝昭ほか. 極低出生体重児における2次元・3次元エコーによる左房駆出率(LAEF)の臨床的意義. 日本周産期・新生児医学会雑誌. 2017, 53(2), 523.
 
17) Niemann PS, et al. Anatomically oriented right ventricular volume measurements with dynamic threedimensional echocardiography validated by 3 -Tesla magnetic resonance imaging. J Am Coll Cardiol. 50(17), 2007, 1668-76.
 
18) Leibundgut G, et al. Dynamic assessment of right ventricular volumes and function by real-time threedimensional echocardiography:a comparison study with magnetic resonance imaging in 100 adult patients. J Am Soc Echocardiogr. 23(2), 2010, 116-26.
 
19) Khoo NS, et al. Assessments of right ventricular volume and function using three-dimensional echocardiography in older children and adults with congenital heart disease:comparison with cardiac magnetic resonance imaging. J Am Soc Echocardiogr. 22(11), 2009, 1279-88.
 
20) 伊藤由依ほか. 肺高血圧症例の3D心エコー両心室解析による検討. 新生児成育医学会雑誌. 29(3), 2017, 612.
 
21) 大村隼也ほか. 先天性横隔膜ヘルニアの重症度と3次元エコーによる右心機能評価との関係. 日本新生児成育医学会雑誌. 30(3), 2018, 673.
 
22) 青木宏諭ほか. 修正満期まで治療を待った重症肺動脈弁狭窄症の早産児2例. 日本周産期・新生児医学会雑誌. 59(suppl), 2023, 276.
 
23) 豊島勝昭ほか. 極低出生体重児における3次元エコー検査による右室機能評価の標準値の検討. 日本新生児成育医学会雑誌. 31(3), 2019, 713.
 
24) 神谷雄作ほか. 早産児の3次元心臓超音波検査:検者間誤差改善への取り組み. 日本新生児成育医学会雑誌. 32(1), 2020, 149-60.
 

Chapter IV 生後早期の適応障害と先天性心疾患

P.170 掲載の参考文献
1) Rudolph AM. "Perinatal and postnatal changes in the circulation". Congenital Diseases of the Heart:Clinical-Physiological Considerations. 3rd ed. Oxford, Wiley-Blackwell, 2009, 25-36.
 
2) Rudolph AM. "The ductus arteriosus and persistent patency of the ductus arteriosus". Congenital Diseases of the Heart:Clinical-Physiological Considerations. 3rd ed. Oxford, Wiley-Blackwell, 2009, 115-47.
 
3) Yokoyama U, et al. Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. J Clin Invest. 16(11), 2006, 3026-34.
 
4) Yokoyama U, et al. Regulation of vascular tone and remodeling of the ductus arteriosus. J Smooth Muscle Res. 46(2), 2010. 77-87. Review.
 
5) Toyoshima K, et al. Left atrial volume is superior to the ratio of the left atrium to aorta diameter for assessment of the severity of patent ductus arteriosus in extremely low birth weight infants. Circ J. 78(7), 2014, 1701-9.
 
6) Toyoshima K, et al. What echocardiographic indices are predictive of patent ductus arteriosus surgical closure in early preterm infants?:A prospective multicenter cohort study. J Cardiol. 74(6), 2019, 512-8.
 
7) Sanjeev S, et al. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol. 25(11), 2005, 709-13.
 
8) 坂野公彦, 池上等, 豊島勝昭ほか. 迅速キットを用いた血中B型ナトリウム利尿ペプチド(BNP)値の経時的測定および極低出生体重児の未熟児動脈管開存症診断における有効性についての検討. 日本未熟児新生児学会雑誌. 20(2), 2008, 233-40.
 
9) Farombi-Oghuvbu I, et al. N-terminal pro-B-type natriuretic peptide:a measure of significant patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 93(4), 2008, F257-60.
 
10) Toyoshima K, et al. In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats. Biol Neonate. 89(4), 2006, 251-6.
 
11) Toyoshima K, et al. In vivo dilatation of the ductus arteriosus induced by furosemide in the rat. The tailor-made circulatory management based on the stress-velocity relationship in preterm infants. J Formos Med Assoc. 112(9), 2013, 510-7.
 
12) Isayama T, et al;Neonatal Research Network of Japan. The effect of professional-led guideline workshops on clinical practice for the management of patent ductus arteriosus in preterm neonates in Japan:a controlled before-and-after study. Implement Sci. 8, 2015, 67.
 
13) 未熟児動脈管開存症診療ガイドライン作成プロジェクトチーム. 根拠と総意に基づく未熟児動脈管開存症治療ガイドライン. 日本未熟児新生児学会雑誌. 22(2), 2010, 255-67.
Medical*Online
14) Toyoshima K, et al. Fetal reversed constrictive effect of indomethacin and postnatal delayed closure of the ductus arteriosus following administration of transplacental magnesium sulfate in rats. Neonatology. 96(2), 2009, 125-31.
 
15) Toyoshima K, et al. In vivo dilatation of the postnatal ductus arteriosus by atrial natriuretic peptide in the rat. Neonatology. 92(2), 2007, 139-44.
 
16) Toyoshima K, et al. In vivo dilatation of the ductus arteriosus induced by furosemide in the rat. Pediatric Res. 67(2), 2010, 173-6.
 
17) Momma K, et al. In vivo dilation of fetal and neonatal ductus arteriosus by inhibition of phosphodiesterase-5 in rats. Pediatr Res. 58(1), 2005, 42-5.
 
18) del Moral T, et al. Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants. J Perinatol. 27(3), 2007, 154-7.
 
19) Masutani S, et al;PLASE(Patent ductus arteriosus and Left Atrial Size Evaluation in preterm infants) study group investigators. Ductus diameter and left pulmonary artery end-diastolic velocity at 3 days of age predict the future need for surgical closure of patent ductus arteriosus in preterm infants:A post-hoc analysis of a prospective multicenter study. J Cardiol. 78(6), 2021, 487-92.
 
20) Tomotaki S, et al;PLASE Study Group Investigators. Proactive Diagnosis and Tailor-Made Treatment of Patent Ductus Arteriosus in Very Preterm Infants with Routine Echocardiography in Japan:A post hoc Analysis of the PLASE Study. Neonatology. 2024 Apr 9:1-9. doi:10.1159/000538363. Online ahead of print.
 
21) Ohlsson A, et al. Ibuprofen for the Treatment of Patent Ductus Arteriosus in Preterm or Low Birth Weight(Or Both)Infants. Cochrane Database Syst Rev. 2020;2(2):CD003481.
 
22) El-Khuffash AF, et al. Assessment and treatment of post patent ductus arteriosus ligation syndrome. J Pediatr. 165(1), 2014, 46-52. e1.
 
23) Noori S, et al;PDA Ligation/Hypotension Trial Investigators. Catecholamine-resistant hypotension and myocardial performance following patent ductus arteriosus ligation. J Perinatol. 35(2), 2015, 123-7.
 
24) Toyoshima K, et al. Biventricular function in preterm infants with patent ductus arteriosus ligation:A threedimensional echocardiographic study. Pediatr Res. 2024 Apr 13. doi:10.1038/s41390-024-03180-w. Online ahead of print.
 
25) Momma K, et al. Delayed neonatal closure of the ductus arteriosus following early in utero exposure to indomethacin in the rat. Neonatology. 96(2), 2009, 69-79.
 
26) 豊島勝昭ほか. 胎児心機能障害におけるナトリウム利尿ペプチドホルモンの臨床的意義. 日本小児循環器学会雑誌. 21(2), 2005, 123-9.
 
27) 豊島勝昭. 新生児内分泌調節と動脈管. 日本周産期・新生児医学会雑誌. 49(1), 2013, 168-71.
 
28) Ohlsson A, Shah PS. Paracetamol(acetaminophen)for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2018;4(4):CD010061.
 
29) Oshima A, et al. Safety and Feasibility of Intravenous Paracetamol for Patent DuctusArteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants:A Case Series. AJP Rep. 10(1), 2020, e49-e53.
 
30) Toyoshima K, et al. Constriction of the ductus arteriosus by selective inhibition of cyclooxygenase-1 and -2 in near-term and preterm fetal rats. Prostaglandins Other Lipid Mediat. 79(1-2), 2006, 34-42.
 
31) Momma K, et al. In vivo constriction of the fetal and neonatal ductus arteriosus by a prostanoid EP4-receptor antagonist in rats. Pediatr Res. 58(5), 2005, 971-5.
 
32) Toyoshima K, et al. Dilatation of the ductus arteriosus by diazoxide in fetal and neonatal rats. Pediatr Int. 59(12), 2017, 1246-51.
 
33) Momma K, et al. Fetal and Neonatal Ductus Arteriosus Is Regulated with ATP-Sensitive Potassium Channel. Etiology and Morphogenesis of Congenital Heart Disease:From Gene Function and Cellular Interaction to Morphology[Internet]. Nakanishi T, et al, eds. Tokyo, Springer, 2016, Chapter 37.
 
34) Toyoshima K, et al. Biventricular function in preterm infants with patent ductus arteriosus ligation:A three-dimensional echocardiographic study. Pediatr Res. 2024 Apr 13. doi:10.1038/s41390-024-03180-w. Online ahead of print.
 
35) Lund JT, et al. Aneurysm of the ductus arteriosus in the neonate:three case reports with a review of the literature. Pediatr Cardiol. 13(4), 1992, 222-6.
 
36) Dyamenahalli U, et al. Isolated ductus arteriosus aneurysm in the fetus and infant:a multi-institutional experience. J Am Coll Cardiol. 36(1), 2000, 262-9.
 
37) Koneti NR, et al. Symptomatic aneurysm of ductus arteriosus in neonates. Ann Pediatr Cardiol. 4(2), 2011, 159-63.
 
38) Hayashi T, et al. A ductal aneurysm rapidly developing into coarctation of the aorta. Eur J Cardiothorac Surg. 43(6), 2013, 1264.
 
39) Dogan V, et al. Thrombosis of isolated ductus arteriosus aneurysm in a newborn. Echocardiography. 38(4), 2021, 716-7.
 
P.203 掲載の参考文献
1) 豊島勝昭ほか. 極低出生体重児における左室壁応力・心筋短縮速度の経時的変化と肺出血・脳室内出血・脳室周囲白質軟化症の関連性について. 日本未熟児新生児学会雑誌. 14(2), 2002, 45-52.
 
2) 豊島勝昭. Stress-Velocity 関係を指標として循環管理した在胎23, 24週の超早産児の検討. 日本周産期・新生児医学会雑誌. 41(3), 2005, 535-42.
 
3) 豊島勝昭. 脳保護を目指した在胎25週未満の超低出生体重児の至適血圧の検討. 日本周産期・新生児医学会雑誌. 45(4), 2009, 1201-4.
 
4) Toyoshima K. Tailor-made circulatory management based on the stress-velocity relationship in preterm infants. J Formos Med Assoc. 112(9), 2013, 510-7.
 
5) 中澤誠. 心機能の発達. 日本新生児学会雑誌. 25(4), 1989, 721-6.
 
6) Grenville FF. "Pulmonary hemorrhage". Neonatal Respiratory Disorders. Greenoough A. et al, eds. London, Arnold, 2003, 365-72.
 
7) Moody DM, et al. Alkaline phosphatase histochemical staining in the study of germinal matrix hemorrhage and brain vascular morphology in a very-low-birth-weight neonate. Pediatr Res. 35(4 Pt 1), 1994, 424-30.
 
8) Ghazi-Birry HS, et al. Human germinal matrix:venous origin of hemorrhage and vascular characteristics. AJNR Am J Neuroradiol. 18(2), 1997, 219-29.
 
9) Shibasaki J, et al. Blood pressure and aEEG in the 96h after birth and correlations with neurodevelopmental outcome in extremely preterm infants. Early Hum Dev. 101, 2016, 79-84.
 
10) 豊島勝昭ほか. 未熟児の低血圧治療にステロイドをルーチンに使用する(ないしは早期に使用する). 周産期医学. 43(9), 2013, 1141-4.
 
11) 大坪善数ほか. 極低出生体重児の三尖弁輪収縮期移動距離による右心機能評価. 日本小児科学会雑誌. 123(10), 2019, 1497-504.
 
12) 豊島勝昭. 新生児の心エコー検査. 日本新生児成育医学会雑誌. 31(2), 2019, 305-11.
 
13) 山本裕ほか. Stress-Velocity 関係に基づく極低出生体重児の循環評価:生後早期におけるインドメタシン静注療法の有効性の検討. 日本未熟児新生児学会雑誌. 19(2), 2007, 43-8.
 
14) 斎藤朋子ほか. 超低出生体重児に対するニトログリセリン静注療法の有効性と安全性の検討. 日本未熟児新生児学会雑誌. 23(3), 2011, 592.
 
15) Toyoshima K, et al. In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats. Biol Neonate. 89(4), 2006, 251-6.
 
16) Toyoshima K, et al. In vivo dilatation of the postnatal ductus arteriosus by atrial natriuretic peptide in the rat. Neonatology. 92(2), 2007, 139-44.
 
17) 豊島勝昭ほか. 新生仔ラットにおけるニトログリセリンの動脈管拡張効果. 日本未熟児新生児学会雑誌. 21(3), 2009, 506.
 
18) Toyoshima K, et al. In vivo dilatation of the ductus arteriosus induced by furosemide in the rat. Pediatric Res. 67(2), 2010, 173-6.
 
19) Miyata M, et al. Extensive use of vasodilator agents and functional echocardiography to monitor extremely-lowb-irth-weight infants in Japan. J Neonatal Perinatal Med. 9(3), 2016, 261-9.
 
P.220 掲載の参考文献
1) Gersony WM. Neonatal pulmonary hypertension:pathophysiology, classification, and etiology. Clin Perinatol. 11(3), 1984, 517-24.
 
2) Rudolph AM. "Perinatal and postnatal changes in the circulation & The ductus arteriosus and persistent patency of the ductus arteriosus". Congenital Diseases of the Heart:Clinical-Physiologic Considerations. New York, Futura Publishing, 2001, 20-9, 155-96.
 
3) 豊島勝昭. "胎児・新生児の循環". 周産期医学必修知識. 第6版. 東京, 東京医学社, 2006, 416-8.
 
4) 川滝元良, 後藤彰子. "新生児遷延性肺高血圧症". 周産期医学必修知識. 第4版. 1996, 401-4.
 
5) 豊島勝昭, 川滝元良. 新生児遷延性肺高血圧症. 新生児診療マニュアル. 第6版. 大山牧子, 星野陸夫編. 東京, 東京医学社, 2014, 214-8.
 
6) 豊島勝昭ほか. 新生児期の肺高血圧と心肺連関を考える. 日本小児呼吸器学会雑誌. 29(2), 2018, 171-7.
 
7) 豊島勝昭. 新生児の心エコー検査. 日本新生児成育医学会雑誌. 31(2), 2019, 305-11.
 
8) 豊島勝昭ほか. 新生児遷延性肺高血圧症(PPHN)に対する血管拡張薬物治療の現状と今後の課題. 日本小児臨床薬理学会雑誌. 21, 2008, 57-60.
 
9) Barrington KJ, et al. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2017;1(1):CD000399.
 
10) Eronen M, et al. Prostacyclin treatment for persistent pulmonary hypertension of the newborn. Pediatr Cardiol. 18(1), 1997, 3-7.
 
11) 埴田卓志ほか. 当科における先天性横隔膜ヘルニアに対するフローラン静注療法の治療経験. Progress in Medicine. 25, 2005, 268-71.
Medical*Online
12) 豊島勝昭. "PPHNの治療にはNOとフローランのどちらを使えばよいですか?". ステップアップ新生児循環管理. 長和俊編. 大阪, メディカ出版, 2017, 258-9.
 
13) Baquero H, et al. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn:a pilot randomized blinded study. Pediatrics. 117(4), 2006, 1077-83.
 
14) Kelly LE, et al. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev. 8(8), 2017, CD005494.
 
15) Toyoshima K, et al. Right to left ventricular volume ratio is associated with mortality in congenital diaphragmatic hernia. Pediatr Res. 94(1), 2023, 304-12.
 
16) Inamura N, et al. A proposal of new therapeutic strategy for antenatally diagnosed congenital diaphragmatic hernia. J Pediatr Surg. 40(8), 2005, 1315-9.
 
17) Tanaka T, et al. The evaluation of diastolic function using the diastolic wall strain(DWS) before and after radical surgery for congenital diaphragmatic hernia. Pediatr Surg Int. 31(10), 2015, 905-10.
 
18) Kimura S, et al. Using airway resistance measurement to determine when to switch ventilator modes in congenital diaphragmatic hernia:a case report. BMC Pediatr. 20(1), 2020, 365.
 
19) Kimura S, et al. Respiratory function testing for guiding ventilator mode conversion in congenital diaphragmatic hernia. Pediatr Pulmonol. 59(3), 2024, 609-16.
 
P.232 掲載の参考文献
1) Celermajer DS, et al. Outcome in neonates with Ebstein's anomaly. J Am Coll Cardiol. 19(5), 1992, 1041-6.
 
2) Asou T, et al. Rapid two-stage starnes approach in high-risk neonates with Ebstein anomaly. Eur J Cardiothorac Surg. 58(5), 2020, 957-63.
 
3) 中澤誠. "重症肺動脈弁狭窄". 先天性心疾患. 東京, メジカルビュー社, 2014, 111-34.
 
4) 上田秀明. "肺動脈狭窄症". 小児疾患の診断治療基準. 小児内科50巻増刊. 東京, 東京医学社, 2018, 524-5.
 
5) Kohler HG. Premature closure of the ductus arteriosus(P.C.D.A.):A possible cause of intrauterine circulatory failure. Early Hum Dev. 2(1), 1978, 15-23.
 
6) 豊島勝昭ほか. 胎児動脈管早期閉鎖の出生前診断例. 日本新生児学会雑誌. 38(3), 2002, 559-64.
 
7) 豊島勝昭ほか. 胎児動脈管早期収縮症(PCDA)の出生前診断. 産婦人科の実際. 54(1), 2005, 185-9.
 
8) Aoki H, et al. Reopening of ductus arteriosus in idiopathic premature constriction or closure of ductus arteriosus:A case series. J Neonatal Perinatal Med. 16(1), 2023, 75-80.
 
9) Zielinsky P, Busato S. Prenatal effects of maternal consumption of polyphenol-rich foods in late pregnancy upon fetal ductus arteriosus. Birth Defects Res C Embryo Today. 99(4), 2013, 256-74.
 
10) Coulson CC, Kuller JA. Nonimmune hydrops fetalis secondary to premature closure of the foramen ovale. Am J Perinatol. 11(6), 1994, 439-40.
 
11) 田仲健一ほか. 左心不全による肺出血と遷延する肺高血圧を合併した胎児期卵円孔閉鎖の1例(原著論文/症例報告). 日本周産期・新生児医学会雑誌. 51(1), 2015, 277-82.
 
12) 本田茜ほか. 胎児卵円孔早期閉鎖および狭小化と出生前診断した18症例における胎児心臓超音波所見と生後臨床経過の検討. 日本小児循環器学会雑誌. 31(1), 2015, s1-200.
 
13) 小豆澤敬幸. 卵円孔早期閉鎖症例における呼吸障害. 日本新生児成育医学会雑誌. 28(3), 2016, 691.
 
P.249 掲載の参考文献
1) Oster M, et al. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics. 131(5), 2013, 1502-8.
 
2) 豊島勝昭ほか. 先天性心疾患の出生前診断が新生児治療に及ぼす影響について. 日本新生児学会雑誌. 36(3), 2000, 477-81.
 
3) 川滝元良. 先天性心疾患の胎児診断:現状の問題点および新しい診断法について. INNERVISION. 28(5), 2013, 55-9.
 
4) 松井彦郎ほか. 先天性心疾患のDetection Rateからみた日本の胎児心臓スクリーニングの課題. 超音波医学. 47, 2020, S368.
 
5) 松井彦郎ほか. 専門的胎児心臓超音波検査の現状による出生前心臓診断の地域格差. 超音波医学. 48, 2021, S775.
 
6) 金基成ほか. オフラインの超音波動画を用いた, 遠隔診断による胎児心臓スクリーニングの精度と効率の検討. 日本周産期・新生児医学会雑誌. 53(3), 2017, 812-816.
 
7) 丸山大介ほか. 神奈川県における4次元超音波技術を用いた胎児心臓超音波勉強会. 日本産科婦人科学会雑誌. 74, 2022, S.590.
 
8) 川滝元良ほか. 重症心疾患の胎児診断率:最近の動向. 神奈川産科婦人科学会誌. 57, 2021, 176-7.
 
9) 金基成. 重症新生児の長期予後と出生前診断:長期予後を踏まえた, 胎児先天性心疾患の診断と方針決定. 日本周産期・新生児医学会雑誌. 57(4), 2022, 787-9.
 
P.253 掲載の参考文献
1) 中澤誠. "総肺静脈還流異常". 先天性心疾患. 東京, メジカルビュー社, 2014, 95-101.
 
2) Craig JM, et al. Total anomalous pulmonary venous drainage into the right side of the heart;report of 17 autopsied cases not associated with other major cardiovascular anomalies. Lab Invest. 6(1), 1957, 44-64.
 
3) Seale AN, et al. Total anomalous pulmonary venous connection:morphology and outcome from an international population-based study. Circulation. 122(25), 2010, 2718-26.
 
P.263 掲載の参考文献
1) Mustard WT. Recent experiences with surgical management of transposition of the great arteries. J Cardiovasc Surg(Torino). 9(6), 1968, 532-6.
 
2) Rudolph AM. "Aortopulmonary transposition". Congenital Diseases of the Heart:Clinical-Physiological Considerations. 3rd ed. Oxford, John Wiley & Sons, 2009, 465-505.
 
3) Maeno YV, et al. Prenatal features of ductus arteriosus constriction and restrictive foramen ovale in d-transposition of the great arteries. Circulation. 99(9), 1999, 1209-14.
 
P.272 掲載の参考文献
1) Celoria GC, et al. Congenital absence of the aortic arch. Am Heart J. 58, 1959, 407-13.
PubMed
2) 豊島勝昭. "先天性心疾患に対するプロスタグランジンE1治療をどう考えるか?". 周産期ケア:エビデンスを求めて. 周産期医学34巻増刊号. 東京, 東京医学社, 2004, 581-4.
 
3) Elliott RB, et al. Medical manipulation of the ductus arteriosus. Lancet. 1(7899), 1975, 140-2.
 
4) 門間和夫. 動脈管とプロスタグランディン. 日本小児科学会雑誌. 82(7), 1978, 633-6.
 
5) Goto J, et al. A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats. Drugs Exp Clin Res. 12(11), 1986, 917-21.
 
6) 門間和夫ほか. Lipo PGE1の動脈管拡張作用. 小児科臨床. 39, 1986, 2441-9.
Medical*Online
7) 丹羽公一郎ほか. リポPGE1の持続効果および蓄積性について:動脈管依存型心疾患にたいして. 日本小児科学会雑誌. 95(1), 1991, 71-4.
 
8) 山村英司ほか. リポプロスタグランディンE1の新生児動脈管拡張作用の持続性. 日本小児循環器学会雑誌. 8, 1992, 436-40.
Medical*Online
9) 与田仁志ほか. 動脈管依存性肺血流現象型心疾患におけるLipoPGE1の中止後の持続効果. 日本小児科学会雑誌. 97, 1993, 1173-7.
 
10) Lim DS, et al. Aminophylline for the prevention of apnea during prostaglandin E1 infusion. Pediatrics. 112(1 Pt 1), 2003, e27-9.
 
11) 豊島勝昭ほか. NICUにおける動脈管依存型先天性心疾患に対するlipoPGE1静注療法の10年間のまとめ. 日本新生児学会雑誌. 39(2), 2003, 275.
 
12) 豊島勝昭ほか. 動脈管依存型先天性心疾患の胎児診断症例における低用量lipo PGE1静注療法. 日本小児循環器科学会雑誌. 20(3), 2004, 277.
 
13) Kobayashi N, et al. Acute gastric outlet obstruction following the administration of prostaglandin:an additional case. Pediatr Radiol. 27(1), 1997, 57-9.
 
14) 朴仁三. "先天性心疾患(解説)". 周産期の症候・診断・治療ナビ. 周産期医学37巻増刊. 東京, 東京医学社, 2007, 700-5.
 
P.297 掲載の参考文献
1) Riko M, et al. Clinical Presentation of Preterm Infants with Ventricular Septal Defect. Tohoku J Exp Med. 252(4), 2020, 281-6.
 
2) Tomotaki H, et al. Clinical features of very-low-birthweight infants with congenital heart disease. Pediatr Int. 63(7), 2021, 806-12.
 
3) Kirklin JW, et al. "Venricular Septal Defect". Cardiac Surgery. 2nd ed. New York, Churchill-Livingstone, 1993, 749.
 
4) Suzuki K, et al. Morphometric analysis of atrioventricular septal defect with common valve orifice. J Am Coll Cardiol. 31(1), 1998, 217-23.
 
5) Riko M, et al. Clinical Presentation of Preterm Infants with Ventricular Septal Defect. Tohoku J Exp Med. 252(4), 2020, 281-6.
 
6) Tomotaki H, et al. Clinical features of very-low-birthweight infants with congenital heart disease. Pediatr Int. 63(7), 2021, 806-12.
 
7) Nakashima Y, et al. Very low birth weight infants with congenital heart disease:A multicenter cohort study in Japan. J Cardiol. 80(4), 2022, 344-50.
 
P.322 掲載の参考文献
1) Quintero RA, et al. Stage-based treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol. 188(5), 2003, 1333-40.
 
2) 村越毅. 多胎と周産期脳障害. 周産期医学. 38(6), 2008, 679-82.
 
3) Mahieu-Caputo D, et al. Pathogenesis of twin-twin transfusion syndrome:the renin-angiotensin system hypothesis. Fetal Diagn Ther. 16(4), 2001, 241-41.
 
4) Mahieu-Caputo D, et al. Paradoxic activation of the renin-angiotensin system in twin-twin transfusion syndrome:an explanation for cardiovascular disturbances in the recipient. Pediatr Res. 58(4), 2005, 685-8.
 
5) 豊島勝昭ほか. 胎児心機能障害におけるナトリウム利尿ペプチドホルモンの臨床的意義. 日本小児循環器学会雑誌. 21(2), 2005, 123-9.
 
6) 豊島勝昭ほか. 一絨毛膜性双胎の胎児・新生児循環の心臓血管内分泌学的検討. 日本周産期・新生児医学会雑誌. 43(4), 2007, 999-1003.
Medical*Online
7) 豊島勝昭ほか. NICU循環管理からみた胎児鏡下胎盤吻合血管レーザー凝固術(FLP)の適応拡大について. 日本周産期・新生児医学会雑誌. 47(4), 2011, 784-7.
 
8) 横山岳彦ほか. 羊水過多過少による双胎間輸血症候群の診断基準を満たさない一絨毛膜二羊膜性双胎の急性期障害と長期予後:アンケート調査から. 日本周産期・新生児医学会雑誌. 53(4), 2017, 966-73.
 
9) 横山岳彦ほか. 一絨毛膜二羊膜性双胎の出生後循環障害の有無と胎児心エコー所見および長期予後との関係について. 日本周産期・新生児医学会雑誌. 54(4), 2018, 990-6.
 
10) 豊島勝昭. 多胎児の新生児合併症とその管理 TTTS:出生直後の循環管理を中心に. 周産期医学. 40(3), 2010, 351-6.
 
11) 豊島勝昭. 多胎児の予後:幼児期予後. 周産期医学. 45(1), 2015, 101-4.
 
12) 豊島勝昭. "心不全における内分泌調節". 新版 新生児内分泌ハンドブック. 大阪, メディカ出版, 272-86.
 
P.332 掲載の参考文献
1) 日本循環器学会ほか. 肺高血圧症治療ガイドライン(2017年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2017/10/JCS2017_fukuda_h.pdf.
 
2) Simonneau G, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 62(25 Suppl), 2013, D34-41.
 
3) Toyoshima K, et al. Right to left ventricular volume ratio is associated with mortality in congenital diaphragmatic hernia. Pediatr Res. 94(1), 2023, 304-12.
 
4) Harjola VP, et al. Contemporary management of acute right ventricular failure:A statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail. 18(3), 2016, 226-41.
 
5) Simonneau G, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 62(25 Suppl), 2013, D34-41.
 
6) Klinger G, et al. Bronchopulmonary dysplasia in very low birth weight infants is associated with prolonged hospital stay. J Perinatol. 26(10), 2006, 640-4.
 
7) Palta M, et al. Respiratory symptoms at age 8 years in a cohort of very low birth weight children. Am J Epidemiol. 154(6), 2001, 521-9.
 
8) Halvorsen T, et al. Characteristics of asthma and airway hyper-responsiveness after premature birth. Pediatr Allergy Immunol. 16(6), 2005, 487-94.
 
9) Chien YH, et al. Rehospitalization of extremely-low-birth-weight infants in first 2 years of life. Early Hum Dev. 66(1), 2002, 33-40.
 
10) Khemani E, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia:clinical features and outcomes in the surfactant era. Pediatrics. 120(6), 2007, 1260-9.
 
11) 川滝元良, 後藤彰子. 慢性肺疾患児の心エコー検査:肺高血圧の定量的評価法(PH score). 周産期医学. 29(6), 1999, 719-24.
 
12) 川滝元良. 肺高血圧症診断法の進歩 超音波イメージング 肺高血圧の半定量評価法(PH score)を中心に. 日本臨床. 59(6), 2001, 1099-106.
 
13) 川滝元良ほか. PH score 測定における検者間誤差の検討. こども医療センター医学誌. 33, 2004, 214-8.
 
14) 野口崇宏ほか. 当院において在宅酸素療法を受けた超低出生体重児の予後検討. 日本小児科学会雑誌. 123(2), 2019, 342.
 
15) 豊島勝昭ほか. 極低出生体重児における3次元エコー検査による右室機能評価の標準値の検討. 日本新生児成育医学会雑誌. 31(3), 2019, 713.
 
16) 小川陽介ほか. 三尖弁輪収縮期移動距離(TAPSE)を用いた小児拡張型心筋症の予後予測の検討. 日本小児循環器学会雑誌. 31(Suppl. 1), 2015, s1-345.
 
17) Katsuaki Toyoshima K, et al. Biventricular function in preterm infants with patent ductus arteriosus ligation:A three-dimensional echocardiographic study. Pediatr Res. 2024 Apr 13. doi:10.1038/s41390-024-03180-w. Online ahead of print.
 
18) Rudolph AM. "Perinatal and postnatal changes in the circulation". Congenital Diseases of the Heart:Clinical-Physiological Considerations. 3rd ed. Oxford, Wiley-Blackwell, 2009, 25-36.
 

Chapter V 循環作動薬の使い方

P.355 掲載の参考文献
1) Toyoshima K, et al. Tailor-made circulatory management based on the stress-velocity relationship in preterm infants. J Formos Med Assoc. 112(9), 2013, 510-7.
 
2) Toyoshima K, et al. LLeft atrial volume is superior to the ratio of the left atrium to aorta diameter for assessment of the severity of patent ductus arteriosus in extremely low birth weight infants. Circ J. 78(7), 2014, 1701-9.
 
3) Artman, M. "PCaridovascular Drug THerapy". Neonatal Cardiology. 2nd ed. New York, McGraw-Hill, 2011, 231-50.
 
4) Ishiguro A, et al. Effect of dopamine on peripheral perfusion in very-low-birth-weight infants during the transitional period. Pediatr Res. 72(1), 2012, 86-9.
 
5) Miyata M, et al. Extensive use of vasodilator agents and functional echocardiography to monitor extremely-lowbirth-weight infants in Japan. J Neonatal Perinatal Med. 9(3), 2016, 261-9.
 
6) Osborn D, et al. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr. 140(2), 2002, 183-91.
 
7) Osborn DA, et al. The effect of inotropes on morbidity and mortality in preterm infants with low systemic or organ blood flow. Cochrane Database Syst Rev. 2007;(1):CD005090.
 
8) Paradisis M, Osborn DA. Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromise. Cochrane Database Syst Rev. 2004;(1):CD003958.
 
9) Seri I. Hydrocortisone and vasopressor-resistant shock in preterm neonates. Pediatr. 117(2), 2006, 516-8.
 
10) Ng PC, et al. A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants. Pediatrics. 117(2), 2006, 367-75.
 
11) Toyoshima K, et al. In vivo dilatation of the ductus arteriosus induced by furosemide in the rat. Pediatr Res. 67(2), 2010, 173-6.
 
12) Rudolph AM. "The ductus arteriosus and persistent patency of the ductus arteriosus". Congenital Diseases of the Heart:Clinical-Physiological Considerations. 3rd ed. Oxford, John Wiley & Sons, 2009, 115-47.
 
13) 未熟児動脈管開存症診療ガイドライン作成プロジェクトチーム. 根拠と総意に基づく未熟児動脈管開存症治療ガイドライン. 日本未熟児新生児学会雑誌. 22(2), 2010, 255-67.
Medical*Online
14) Ohlsson A, et al. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight(or both)infants. Cochrane Database Syst Rev. 2015;2:CD003481
 
15) Mitra S, et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants:A systematic review and meta-analysis JAMA. 319(12), 2018, 1221-38.
 
16) Giaccone A, et al. Milrinone Pharmacokinetics and Pharmacodynamics in Neonates with Persistent Pulmonary Hypertension of the Newborn. Am J Perinatol. 34(8), 2017, 749-58.
 
17) Toyoshima K, et al. In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in ratsIn vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats. Biol Neonate. 89(4), 2006, 251-6.
 
18) Toyoshima K, et al. In vivo dilatation of the postnatal ductus arteriosus by atrial natriuretic peptide in the ratin vivo dilatation of the postnatal ductus arteriosus by atrial natriuretic peptide in the rat. Neonatology. 92(2), 2007, 139-44.
 
19) Barrington KJ, et al. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2017;1(1):CD000399.
 
20) Ahmad KA, et al. Intravenous epoprostenol improves oxygenation index in patients with persistent pulmonary hypertension of the newborn refractory to nitric oxide. J Perinatol. 38(9), 2018, 1212-19.
 
21) Kelly LE, et al. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev. 2017;8:CD005494.
 
22) Momma K, et al. In vivo dilation of fetal and neonatal ductus arteriosus by inhibition of phosphodiesterase-5 in rats. In vivo dilation of fetal and neonatal ductus arteriosus by inhibition of phosphodiesterase-5 in rats. 58(1), 2005, 42-5.
 
23) Steinhorn RH, et al. Bosentan as adjunctive therapy for persistent pulmonary hypertension of the newborn:Results of the randomized multicenter placebo-controlled exploratory trial. J Pediatr. 177, 2016, 90-96.e3.
 
24) Momma K, et al. Inhibition of in vivo constriction of fetal ductus arteriosus by endothelin receptor blockade in rats. Pediatr Res. 53(3), 2003, 479-85.
 
25) Shivanna B, et al. Vasopressin and its analogues for the treatment of refractory hypotension in neonates. Cochrane Database Syst Rev. 2013;(3):CD009171.
 

書評

最近チェックした商品履歴

Loading...